Company: BSX
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0000885725-25-000050
Chunk: 40

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 1
Chunk 40
---
 assets1,832 1,754 TOTAL ASSETS$42,707 $39,395 LIABILITIES AND STOCKHOLDERS’ EQUITY  Current liabilities:  Current debt obligations$483 $1,778 Accounts payable1,002 960 Accrued expenses2,981 2,773 Other current liabilities862 887 Total current liabilities5,328 6,399 Long-term debt11,117 8,968 Deferred tax liabilities242 155 Other long-term liabilities2,390 1,870 Commitments and contingenciesStockholders’ equity  Preferred stock, $0.01 par value - authorized 50,000,000 shares - 0 shares issued as of September 30, 2025 and December 31, 2024— — Common stock, $0.01 par value - authorized 2,000,000,000 shares - 1,745,573,129 shares  issued as of September 30, 2025 and 1,737,846,196 shares issued as of December 31, 202417 17 Treasury stock, at cost - 263,289,848 shares as of September 30, 2025 and December 31, 2024(2,251)(2,251)Additional paid-in capital21,419 21,056 Retained earnings4,899 2,673 Accumulated other comprehensive income (loss), net of tax(689)275 Total stockholders’ equity23,394 21,770 Noncontrolling interests236 233 Total equity23,630 22,003 TOTAL LIABILITIES AND EQUITY$42,707 $39,395 

Refer to notes to the unaudited consolidated financial statements. Amounts may not add due to rounding.

5

Table of Contents

BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,(in millions, except share data)2025202420252024Common stock shares issuedBeginning1,743,632,871 1,734,329,744 1,737,846,196 1,729,000,224 Impact of stock-based compensation plans1,940,258 2,401,651 7